January 27th 2025
The 2025 Pharmapack Awards recognize both commercial products and innovations that are shaping the future of pharmaceutical packaging.
Catalent Appoints New Vice President of Open Innovation, Biologics, Cell and Gene Therapy
November 30th 2020Behzad Mahdavi, PhD, will join a team of experts in the company’s Science and Technology Group to fast-track the adoption of new development and drug delivery technologies and manufacturing processes and techniques.
Bilim, H&T Presspart, and Hovione Partner to Bring Asthma Product to the Turkish Market
September 1st 2020The Ventofor Combi Fix will be brought into the Turkish market via Bilim’s development program, while the PowdAir Plus DPI is manufactured and commercialized by H&T Presspart under a patent license from Hovione.
EC Grants Marketing Authorization for Subcutaneous Formulation of Daratumumab
June 5th 2020The European Commission has granted marketing authorization to the Janssen Pharmaceutical Companies of Johnson & Johnson for Darzalex (daratumumab) subcutaneous formulation to treat adults with multiple myeloma.
TAE Life Sciences to Launch Drug Delivery Program After $30-Million Investment
June 4th 2020The investment will give the company the opportunity to accelerate the development of proprietary boron-10 target drugs while it develops its neutron beam accelerator technology for Boron Neutron Capture Therapy.
Improving the Patient Experience with High Viscosity/High Volume Drugs
October 17th 2019On Tuesday, Nov. 5, 2019, Karima Yadi from Becton Dickinson & Co. will present the challenges of using, and necessity for, shorter needles and integrated systems with high viscosity drugs, such as biologics, to improve the patient experience at CPhI Worldwide.